Canine mammary tumors (CMTs) are the most common neoplasm in intact female dogs.
Canine mammary cancer (CMC) represents 50% of CMTs, and besides surgery, which is the …

Immunotherapy has moved to the forefront of modern oncologic treatment in the past few
decades. Various forms of immunotherapy currently are emerging, including oncolytic …

Maintaining the balance between eliciting immune responses against foreign proteins and
tolerating self-proteins is crucial for maintenance of homeostasis. The functions of …

Triple‑negative breast cancer (TNBC) is a highly heterogeneous and aggressive
malignancy. Due to the absence of estrogen receptors and progesterone receptors and the …

Biological therapy is considered an alternative treatment capable of eliciting the same
effects on tumors as surgery, radiotherapy, and chemotherapy. As a major player in …

Immunotherapy is at the cutting edge of modern cancer treatment. Innovative medicines
have been developed with varying degrees of success that target all aspects of tumor …

Breast cancer is the second most common kind of cancer worldwide and oncolytic viruses
may offer a new treatment approach. There are three different types of oncolytic viruses used …

The field of oncolytic virotherapy has seen remarkable advancements in last two decades,
leading to approval of the first oncolytic immuno-virotherapy, Talimogene Laherparepvec, for …

The worldwide burden of cancers is increasing at a very high rate, including the aggressive
and resistant forms of cancers. Certain levels of breakthrough have been achieved with the …

Although it is known that oncolytic viruses can inflame and recruit immune cells to otherwise
immunosuppressed tumor microenvironments, the influence of the antiviral immune …